Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3256 AL 3270

MicroRNAs for the Treatment of Dementia and Alzheimer's Disease

Maiese K.

Curr Neurovasc Res. 2019;16(1):1-2. doi: 10.2174/1567202616666190208094159.

Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease

Jojo GM, Kuppusamy G.

J Clin Pharm Ther. 2019 Jun;44(3):337-348. doi: 10.1111/jcpt.12808. Epub 2019 Feb 9.

Tacrines for Alzheimer's disease therapy. III. The PyridoTacrines

de Los Ríos C, Marco-Contelles J.

Eur J Med Chem. 2019 Mar 15;166:381-389. doi: 10.1016/j.ejmech.2019.02.005. Epub 2019 Feb 4.

Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer's Disease

Zhang X, Lao K, Qiu Z, Rahman MS, Zhang Y, Gou X.

J Alzheimers Dis. 2019;67(4):1109-1122. doi: 10.3233/JAD-181084.

Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018)

Mishra P, Kumar A, Panda G.

Bioorg Med Chem. 2019 Mar 15;27(6):895-930. doi: 10.1016/j.bmc.2019.01.025. Epub 2019 Jan 25.

The Effectiveness of Vitamin E Treatment in Alzheimer's Disease

Lloret A, Esteve D, Monllor P, Cervera-Ferri A, Lloret A.

Int J Mol Sci. 2019 Feb 18;20(4):879. doi: 10.3390/ijms20040879.

Comparative Serum Proteomic Analysis of the Effects of Sodium Selenate on a Mouse Model of Alzheimer's Disease

Chen P, Wang LX, Sui XJ, Li SM, Wang Y, Liu Q, Ni JZ.

Biol Trace Elem Res. 2019 Dec;192(2):263-276. doi: 10.1007/s12011-019-01676-9. Epub 2019 Feb 21.

Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer's Disease

Li R, Zhang Y, Rasool S, Geetha T, Babu JR.

Oxid Med Cell Longev. 2019 Jan 17;2019:8165707. doi: 10.1155/2019/8165707. eCollection 2019.

The emergence of Ephexin5 as a therapeutic target in Alzheimer's disease

Cook EK, Sell GL, Schaffer TB, Margolis SS.

Expert Opin Ther Targets. 2019 Apr;23(4):263-265. doi: 10.1080/14728222.2019.1586884. Epub 2019 Mar 5.

Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues

Ittner LM, Klugmann M, Ke YD.

Br J Pharmacol. 2019 Sep;176(18):3649-3665. doi: 10.1111/bph.14637. Epub 2019 Apr 23.

Natural barrigenol-like triterpenoids: A comprehensive review of their contributions to medicinal chemistry

Zhang X, Zhang S, Yang Y, Wang D, Gao H.

Phytochemistry. 2019 May;161:41-74. doi: 10.1016/j.phytochem.2019.01.017. Epub 2019 Feb 26.

Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease

Mezeiova E, Chalupova K, Nepovimova E, Gorecki L, Prchal L, Malinak D, Kuca K, Soukup O, Korabecny J.

Curr Alzheimer Res. 2019;16(9):772-800. doi: 10.2174/1567205016666190228122956.

Liraglutide and its Neuroprotective Properties-Focus on Possible Biochemical Mechanisms in Alzheimer's Disease and Cerebral Ischemic Events

Wiciński M, Socha M, Malinowski B, Wódkiewicz E, Walczak M, Górski K, Słupski M, Pawlak-Osińska K.

Int J Mol Sci. 2019 Feb 28;20(5):1050. doi: 10.3390/ijms20051050.

Pharmacological Interventions to Attenuate Alzheimer's Disease Progression: The Story So Far

Bazzari FH, Abdallah DM, El-Abhar HS.

Curr Alzheimer Res. 2019;16(3):261-277. doi: 10.2174/1567205016666190301111120.

A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment

Das B, Yan R.

CNS Drugs. 2019 Mar;33(3):251-263. doi: 10.1007/s40263-019-00613-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias